11.75
price down icon1.51%   -0.18
after-market アフターアワーズ: 11.75
loading
前日終値:
$11.93
開ける:
$11.9
24時間の取引高:
204.55K
Relative Volume:
0.25
時価総額:
$640.80M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+7.50%
1か月 パフォーマンス:
+31.43%
6か月 パフォーマンス:
+1.25%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$11.69
$12.01
1週間の範囲:
Value
$10.94
$12.03
52週間の値動き範囲:
Value
$7.80
$28.09

Bicara Therapeutics Inc Stock (BCAX) Company Profile

Name
名前
Bicara Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
617-785-8308
Name
住所
245 MAIN STREET, CAMBRIDGE
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
BCAX's Discussions on Twitter

BCAX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BCAX
Bicara Therapeutics Inc
11.75 642.98M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-23 アップグレード Wells Fargo Underweight → Equal Weight
2025-04-17 開始されました Wells Fargo Underweight
2025-02-06 開始されました Wedbush Outperform
2024-12-06 開始されました H.C. Wainwright Buy
2024-11-05 開始されました Rodman & Renshaw Buy
2024-10-08 開始されました Cantor Fitzgerald Overweight
2024-10-08 開始されました Morgan Stanley Overweight
2024-10-08 開始されました Stifel Buy
2024-10-08 開始されました TD Cowen Buy
すべてを表示

Bicara Therapeutics Inc (BCAX) 最新ニュース

pulisher
01:38 AM

What analysts say about Bicara Therapeutics Inc. stock outlookHigh-margin investment plays - jammulinksnews.com

01:38 AM
pulisher
Jul 24, 2025

Is Bicara Therapeutics Inc. stock a good hedge against inflationExtraordinary profit generation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Bicara Therapeutics Inc. stock benefit from interest rate changesDynamic investment growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Bicara Therapeutics Inc. a good long term investmentConsistently exceptional gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Bicara Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Bicara Therapeutics Inc. stock priceHigh-velocity gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Bicara Therapeutics Inc. stockHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Bicara Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser

Jul 22, 2025
pulisher
Jul 17, 2025

Analysts Set Bicara Therapeutics Inc. (NASDAQ:BCAX) Price Target at $31.86 - Defense World

Jul 17, 2025
pulisher
Jul 15, 2025

Why Bicara Therapeutics Inc. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Bicara Therapeutics Inc. stock price move sharplyInvestor Friendly Risk Reward - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

Merus, Bicara Present Promising HNSCC Trial Data at ASCO 2025, Advance Towards Phase III - Yahoo Finance

Jul 08, 2025
pulisher
Jun 25, 2025

GAMMA Investing LLC Purchases 7,694 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) - Defense World

Jun 25, 2025
pulisher
Jun 12, 2025

Bicara Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Petri Dish: Scorpion spinout debuts with $177M, Bicara doubles footprint - The Business Journals

Jun 12, 2025
pulisher
Jun 11, 2025

# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Relay Therapeutics Strengthens Board with Precision Medicine Expert as Phase 3 Cancer Trial Approaches - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus (NASDAQ:BCAX) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Bicara Therapeutics Inc. (NASDAQ:BCAX) Holdings Raised by Bank of America Corp DE - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates BCAX FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Morgan Stanley Maintains Buy Rating on Bicara (BCAX) After the Ficerafusp Alfa Trial Update - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Stifel maintains Buy rating, $48 target on Bicara Therapeutics stock By Investing.com - Investing.com Nigeria

Jun 10, 2025

Bicara Therapeutics Inc (BCAX) 財務データ

Bicara Therapeutics Inc (BCAX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bicara Therapeutics Inc (BCAX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Meisner Lara
Chief Legal Officer
Jun 16 '25
Sale
10.43
15,829
165,096
0
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):